Evidence map›Paper›PMID 18505433›Full record

ArticleClinical and experimental immunology2008

Effect of tumour necrosis factor-alpha receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept.

E Mazzon, E Esposito, R Di Paola, C Muià, C Crisafulli, T Genovese, R Caminiti, R Meli, P Bramanti, S Cuzzocrea

Open access · greenAbstract readComparative Study
In one paragraph

Article in Clinical and experimental immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Biochemistry and biophysics reports · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Systemic changes following carrageenan-induced paw inflammation in rats.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2015
    Article
  12. Article
  13. Article
  14. Article
  15. Anti-inflammatory effect of quinoline alkaloid skimmianine isolated from Ruta graveolens L.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2013
    Article
  16. Article
  17. Article
  18. Article
  19. TNF/TNFR1 signaling mediates doxorubicin-induced diaphragm weakness.American journal of physiology. Lung cellular and molecular physiology · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

E MazzonDepartment of Clinical and Experimental Medicine and Pharmacology, School of Medicine, University of Messina, Messina, Italy.
E Esposito
R Di Paola
C Muià
C Crisafulli
T Genovese
R Caminiti
R Meli
P Bramanti
S Cuzzocrea
Centro Neurolesi Bonino Pulejo · ITUniversity of Messina · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study, we used tumour necrosis factor-alpha receptor 1 knock-out mice (TNF-alphaR1KO) to evaluate an in vivo role of TNF-alphaR1 on the pathogenesis of inflammatory diseases. We used a murine model of carrageenan-induced acute inflammation (pleurisy), a preclinical model of airway inflammation. The data proved that TNF-alphaR1KO were resistant to carrageenan-induced acute inflammation compared with TNF-alpha wild-type mice. TNF-alphaR1KO showed a significant reduction in accumulation of pleural exudate and in the number of inflammatory cells, in lung infiltration of polymorphonuclear leucocytes and lipid peroxidation and showed a decreased production of nitrite/nitrate in pleural exudates. Furthermore, the intensity and degree of the adhesion molecule intercellular adhesion molecule-1 and P-selectin, Fas ligand (FasL), inducible nitric oxide sythase and nitrotyrosine determined by immunohistochemical analysis were reduced markedly in lung tissues from TNF-alphaR1KO at 4 h and 24 h after carrageenan injection. Moreover, TNF-alpha and interleukin-1beta concentrations were reduced in inflamed areas and in pleural exudates from TNF-alphaR1KO. To support the results generated using pleural inflammation, carrageenan-induced paw oedema models were also performed. In order to elucidate whether the observed anti-inflammatory effects were related to the inhibition of TNF-alpha, we also investigated the effect of etanercept, a TNF-alpha soluble receptor construct, on carrageenan-induced pleurisy. The treatment with etanercept (5 mg/kg subcutaneously 2 h before the carrageenan injection) reduces markedly both laboratory and histological signs of carrageenan-induced pleurisy. Our results showed that administration of etanercept resulted in the same outcome as that of deletion of the TNF-alphaR1 receptor, adding a new insight to TNF-alpha as an excellent target by therapeutic applications.

Indexed as

Acute DiseaseAnimalsBiomarkersCarrageenanEdemaEtanerceptFas Ligand ProteinGene DeletionHindlimbImmunoglobulin GImmunohistochemistryIntercellular Adhesion Molecule-1Interleukin-1LungMaleMice3-nitrotyrosineBiomarkersCarrageenanEtanerceptFas Ligand ProteinImmunoglobulin GIntercellular Adhesion Molecule-1Interleukin-1P-SelectinReceptors, Tumor Necrosis FactorReceptors, Tumor Necrosis Factor, Type IThiobarbituric Acid Reactive SubstancesTumor Necrosis Factor-alphaTyrosine

Identifiers

PMID18505433
PMCPMC2432107
OpenAlexW1977130139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.